Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01471756 · ClinicalTrials.gov registry record · Phase 4
Improving Complete Endoscopic Mucosal Resection (EMR) of Colorectal Neoplasia
A Phase 4 study of Neoplasms and Gastric Cancer, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 4
- Development phase
- 66
- Enrollment target
- 1
- Study location
NCT01471756 is a Phase 4 study of Neoplasms and Gastric Cancer that has completed, run by Mayo Clinic. The registered enrollment target is 66 participants, below the 1,621-participant average among 158 other Neoplasms trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01471756, a Phase 4 study of Neoplasms and Gastric Cancer, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 66 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators seek to compare two techniques of removing pre-cancerous lesions from the colon. The investigators also will compare two solutions used during the procedure to determine if either solution allows for an improved removal of the tumors.
Conditions Studied
Interventions
- PROCEDURE Standard of Care Procedure as described in ARM
Study Locations (1)
Florida
- Mayo Clinic - Jacksonville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2011-10 |
| Est. Completion | 2014-05 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01471756
The ClinicalTrials.gov registry entry for NCT01471756 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 66 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,621-participant average among 158 other Neoplasms trials with a reported enrollment target (96% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Neoplasms appearing as the primary indexed condition, and to 1 intervention - of which Standard of Care Procedure as described in ARM is the first listed.
NCT01471756 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT01471756 about?
NCT01471756 is a clinical study titled "Improving Complete Endoscopic Mucosal Resection (EMR) of Colorectal Neoplasia". The investigators seek to compare two techniques of removing pre-cancerous lesions from the colon. The investigators also will compare two solutions used during the procedure to determine if either solution allows for an improved removal of the tumors.
What is the current status of trial NCT01471756?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 66 participants. The study started on 2011-10. Estimated completion is 2014-05.
What conditions does trial NCT01471756 study?
This clinical trial studies the following conditions: Neoplasms, Gastric Cancer.
What interventions are being tested in trial NCT01471756?
The interventions under investigation include: Standard of Care Procedure as described in ARM (PROCEDURE).
Who is sponsoring clinical trial NCT01471756?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01471756 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Neoplasms
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
18F-Fluciclovine PET/CT Impact on Predicting Clinical Outcome of 177Lu-PSMA-617 Therapy in Patients With Prostate Cancer
RECRUITING · Phase 4
-
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Clinical Activity of RO7673396 in Participants With Advanced Solid Tumors Harboring Rat Sarcoma Viral Oncogene Homolog (RAS) Mutation(s)
RECRUITING · Phase 1
-
Real World Registry for Use of the Ion Endoluminal System
RECRUITING
-
A Study of GSK5764227 in Participants With. Advanced Solid Tumors (EMBOLD PanTumor-101)
RECRUITING · Phase 1
-
Endometrial Cell Collection With the PadKit
RECRUITING · NA
-
Adoptive Cell Therapy Long-term Follow-up (LTFU) Study
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.